Vice-Chair of Pathology and Section Chief of Molecular and Genetic Pathology, Augusta UniversityBiography
Dr. Ravindra Kolhe the Vice-Chair of Pathology and Section Chief of Molecular and Genetic Pathology at Augusta University, is the lead investigator of the COVID-19 Host Genome Structural Variation Consortium. He is also one of the co-investigators in the State of Georgia Public Health Department Ongoing Task Force for viral RNA testing and serology surveillance program for the public. Dr. Kolhe intends to build a global network of researchers who can contribute to our collective knowledge on host genome response to the SARS-CoV-2 infection and COVID-19 disease.
As a Molecular and Genetic Pathologist, I am actively engaged in molecular and cytogenetic evaluation of patient samples as a part of the multi- disciplinary clinical team treating patients. It is my goal to render not only the most accurate diagnosis but also to provide and develop the highest quality predictive and prognostic tests as a part of personalized medicine. This approach helps my clinical colleagues take the best possible care of the patient while at the same time advancing our scientific knowledge in these areas. My clinical work involves molecular evaluation of various pathologic disorders and malignancies.